Ethical Profile
Mixed.
Not enough information to create an ethical profile.
HQL.US | Trusts, funds and similar financial entities
H & Q Life Sciences Investors (HQL.US) is a closed-end investment fund/investment trust company. The fund primarily focuses on investments in the life sciences sector. This includes companies involved in pharmaceuticals, biotechnology, medical devices, diagnostics, and healthcare services. The fund ...Show More
Ethical Profile
Not enough information to create an ethical profile.
Similar Companies
No evidence available to assess H & Q Life Sciences Investors on Better Health for All.
HQL.US is a closed-end investment fund focused on the life sciences sector. Its core business involves investing in companies, not providing direct lending, deposit, or consumer financial services. Therefore, the KPIs under 'Fair Money & Economic Opportunity,' which are designed to assess financial institutions offering consumer-facing financial products and services, are not applicable to HQL.US's business model. No evidence was found in the provided articles to suggest HQL.US engages in activities relevant to these KPIs.
No specific, quantitative data for HQL.US was found across the provided articles for any of the Fair Pay & Worker Respect KPIs. The articles primarily consist of general reports on HR trends, compensation practices, and societal wage gaps, rather than company-specific performance metrics for HQL.US.
HQL.US is a closed-end investment fund focused on the life sciences sector. Its core business involves managing investments, not procuring or trading physical commodities, operating a traditional supply chain, or engaging in manufacturing. Therefore, the KPIs related to fair trade certifications, supplier audits, forced/child labor incidents, supply chain traceability, remediation processes, ethical sourcing clauses, high-risk material sourcing, and supplier diversity spend are not applicable to the company's direct operations.
No specific evidence was found in the provided articles to assess HQL.US against any of the KPIs for the 'Honest & Fair Business' ethical value. While the company is noted to file various reports with the Securities and Exchange Commission (SEC), including annual reports (10K), news updates (8K), and ownership reports
No specific, concrete evidence was found in the provided articles regarding HQL.US (H & Q Life Sciences Investors)'s performance against any of the 'Kind to Animals' KPIs. The articles discuss general industry trends, regulatory changes, or refer to other companies (Integra LifeSciences, HQ Capital), not HQL.US directly.
No specific, concrete data points were found in the provided articles for HQL.US regarding any of the 'No War, No Weapons' KPIs. The articles primarily consist of financial reports for the investment fund or general discussions about ESG regulations and dual-use technologies, none of which provide direct evidence of HQL.US's involvement or policies related to arms contracts, dual-use technology, sales to embargoed regimes, peacebuilding investments, or any other relevant metrics.
No evidence available to assess H & Q Life Sciences Investors on Planet-Friendly Business.
No specific, concrete data points were found in the provided articles regarding HQL.US's respect for cultures and communities.
No evidence available to assess H & Q Life Sciences Investors on Safe & Smart Tech.
No evidence available to assess H & Q Life Sciences Investors on Zero Waste & Sustainable Products.
Upload your portfolio and see how all your holdings score across 11 ethical dimensions.
Audit My PortfolioAI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.